Zobrazeno 1 - 10
of 68
pro vyhledávání: '"James Garner"'
Autor:
James Garner, Matthew D. Egbert
Publikováno v:
Frontiers in Computer Science, Vol 4 (2022)
Living systems process sensory data to facilitate adaptive behavior. A given sensor can be stimulated as the result of internally driven activity, or by purely external (environmental) sources. It is clear that these inputs are processed differently
Externí odkaz:
https://doaj.org/article/d911aee8c5c44eccb70fcf5ecb1678fa
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21717 (2011)
Epothilones are a new class of microtubule stabilizing agents with promising preclinical and clinical activity. Their cellular target is β-tubulin and factors influencing intrinsic sensitivity to epothilones are not well understood. In this study, t
Externí odkaz:
https://doaj.org/article/f37e4dc8e92540b894de59f20af6d5d8
Autor:
Patrick Y Wen, John de Groot, James Battiste, Samuel Goldlust, Denise Damek, Benjamin Ellingson, James Garner, John Friend, Jeremy Simpson, Alan Olivero, Timothy Cloughesy
Publikováno v:
Neuro-Oncology. 24:vii76-vii77
NCT03522298 was an open-label, multi-center, 2-stage trial designed to establish the maximum tolerated dose (MTD) for once-daily (QD) paxalisib dosing (Stage 1), then evaluate pharmacokinetics(PK) and safety and explore efficacy (Stage 2). Eligible p
Autor:
James Garner
Publikováno v:
International Review of Applied Linguistics in Language Teaching. 60:909-935
Previous studies utilizing association measures for collocation analysis have demonstrated significant differences in second language (L2) collocation production across proficiency levels. However, the association strength measures utilized in these
Autor:
James Garner, Matthew Egbert
Publikováno v:
The 2022 Conference on Artificial Life.
Autor:
Daniel J. Berg, Jermaine Coward, Kathleen N. Moore, Paul R. Harnett, James Garner, Ganessan Kichenadasse, Don S. Dizon, Minal A. Barve
Publikováno v:
Cancers, Vol 13, Iss 3196, p 3196 (2021)
Cancers
Volume 13
Issue 13
Cancers
Volume 13
Issue 13
Survival outcomes in ovarian cancer are poor. The aims of this Phase I progressive design study (NCT02903771) were to evaluate the maximum tolerated dose (MTD), tolerability, and antitumor activity of Cantrixil—a novel third-generation benzopyran m
Publikováno v:
System. 80:176-187
Productive knowledge of English phraseology can assist second language writers in composing more effective and target-like texts. As such, researchers have taken a great interest in L2 phraseological competence by comparing the use of multi-word sequ
Autor:
Michael R. Paillasse, James Garner, Michael Fitzgerald, Lise Davenne, Pierre-Benoit Ancey, celine Poussereau-Pomie, Michael Esquerre, Gaelle Badet, Joel Tuyaret, Marie Mandron, Philippe Rochaix, Maha Ayyoub, Clara Maria Scarlata, Christine Ménétrier-Caux, Chrsitophe CAUX, Philippe Cassier, Jean-Pierre Delord, Carlos Gomez Roca, Pierre Fons
Publikováno v:
Cancer Research. 82:3203-3203
Introduction: EVT801 is a highly selective small molecule inhibitor of VEGFR3 and acts by inhibiting lymphangiogenesis and tumor angiogenesis in and around the tumor. It has shown compelling activity in a wide range of cancer models and is well-toler
Autor:
Carlos Gomez roca, Philippe Cassier, Marie Mandron, Myriam Estrabaut, Nathalie Delesque-Touchard, Adam C. Smith, Amy Klawitter, Leesa Gentry, Pierre Fons, Michael R. Paillasse, Lise Davenne, Michael Fitzgerald, James Garner, Jean-Pierre Delord
Publikováno v:
Cancer Research. 82:CT206-CT206
Introduction: EVT801 is a highly selective, orally available VEGFR3 inhibitor that strongly inhibits angiogenesis without inducing hypoxia, considered one of the main causes of cancer-associated immunosuppression. EVT801 has shown compelling single a